Evoqua Water to use revolver borrowings for Mar Cor purchase

By Sara Rosenberg

New York, Dec. 20 – Evoqua Water Technologies plans to use its revolving credit facility and cash on hand to fund the $196.3 million acquisition of the Mar Cor Purification and Cantel Medical subsidiaries of Steris plc, according to a news release.

Closing is expected in Evoqua’s second quarter of fiscal 2022, which ends March 31, 2022, subject to customary conditions, including regulatory review.

Evoqua is a Pittsburgh-based provider of mission critical water and wastewater treatment solutions. Mar Cor is a Plymouth, Minn.-based manufacturer and servicer of medical water, commercial and industrial solutions.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.